GSK has become the latest drugmaker to run into difficulties in developing a drug targeting the immune checkpoint receptor TIM-3, after its cobolimab candidate flunked a phase 3 trial in lung cancer.

Tim David's scintillating, unbeaten century helped Australia make a total mockery of West Indies' lofty 214/4 as they chased it down with 23 balls to spare. David, who hit 11 sixes in his incredible ...